Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan
bictegravir-based regimens are a valid therapeutic option for people living with HIV, particularly for those with metabolic comorbidities.
Authors
- Marcello Trizzino (ORCID: https://orcid.org/0000-0002-8105-5139)
- Luca Pipitò (ORCID: https://orcid.org/0000-0002-1871-4285)
- Claudia Gioè
- Antonio Cascio (ORCID: https://orcid.org/0000-0002-1992-1796)
- Roberta Gaudiano
- Dalila Arena
Institutions
- Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Viruses
- Published
- 2025-03-19
- DOI
- https://doi.org/10.3390/v17030440
- Citations
- 2
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.79